|Articles|January 15, 2003
- BioPharm International-01-01-2003
- Volume 16
- Issue 1
Market Views: A Rocky Road for Generics
Author(s)Kevin Robinson
by Kevin Robinson For "me too" manufacturers, the growth opportunity is in Europe ? and in biogenerics.
Advertisement
Articles in this issue
almost 23 years ago
Biotech World: Canada's Supreme Court says "No" to Harvard Mousealmost 23 years ago
Guest Editorial: At the Governance Crossroadalmost 23 years ago
Reducing Costs by Facility Designalmost 23 years ago
Guidelines for Optimization and Scale-Up in Preparative ChromatographyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
2
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
3
BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints
4
Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization
5

